OverviewZogenix, Inc. (Nasdaq: ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
NASDAQ | ZGNX (Common Stock)
$9.92 - 0.08
Data as of 05/27/16 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.
Investor Events More
Tuesday, May 10, 2016 4:30 p.m. ET
Q1 2016 Zogenix, Inc. Earnings Conference Call
Wednesday, February 10, 2016 10:40 a.m. ET
Zogenix, Inc. at LEERINK Partners 5th Annual Global Healthcare Conference